Literature DB >> 9681777

The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline.

R N Juste1, K Panikkar, N Soni.   

Abstract

OBJECTIVE: To investigate whether low-dose dopamine (LDD) has a significant effect on systemic haemodynamic variables and renal function when used in conjunction with high-dose noradrenaline in optimally volume-resuscitated patients with septic shock.
DESIGN: A prospective clinical study in which each patient acted as his/her own control.
SETTING: Teaching hospital Intensive Care Unit. PATIENTS: Twenty-one patients with septic shock treated with high-dose noradrenaline were studied, 17 patients completed the study.
INTERVENTIONS: Fluid loading to an optimal left ventricular stroke work index (LVSWI) whilst on more noradrenaline than 10 mcg/min and dopamine of 2.5 mcg/kg per min. Three study periods each of 2 h with LDD present, withdrawn and restarted. During each period a complete haemodynamic profile and measurement of urine flow rate, creatinine clearance and sodium excretion was performed. MEASUREMENT AND
RESULTS: Removing and restarting LDD caused marked changes in cardiac index (CI, 17% fall, p < 0.01: 23% rise, p < 0.01), stroke volume (SV, 11% fall, p < 0.05: 14% rise, p < 0.05) and systolic blood pressure (SBP, 11% fall, p < 0.05: 14% rise, p < 0.05). Urine volume fell by 40% (p < 0.05) when dopamine was withdrawn. Significant reductions in sodium excretion (p < 0.05) and fractional sodium excretion (p < 0.05) also occurred on stopping LLD. Changes in creatinine clearance were not statistically significant.
CONCLUSION: Low-dose dopamine causes significant increases in SBP SV, cardiac output and urine flow during treatment with noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681777     DOI: 10.1007/s001340050616

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

1.  Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.

Authors:  T Lherm; G Troché; M Rossignol; P Bordes; J F Zazzo
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

2.  Two-hour versus 22-hour creatinine clearance in critically ill patients.

Authors:  R N Sladen; E Endo; T Harrison
Journal:  Anesthesiology       Date:  1987-12       Impact factor: 7.892

Review 3.  Dopamine--clinical uses of an endogenous catecholamine.

Authors:  L I Goldberg
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

4.  Renal vascular responses to dopamine: haemodynamic and angiographic observations in normal man.

Authors:  N K Hollenberg; D F Adams; P Mendell; H L Abrams; J P Merrill
Journal:  Clin Sci Mol Med       Date:  1973-12

Review 5.  Acute renal failure in the intensive care unit. Part 2.

Authors:  H L Corwin; J V Bonventre
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

6.  Steady-state dopamine clearance in critically ill infants and children.

Authors:  A Zaritsky; A Lotze; R Stull; D S Goldstein
Journal:  Crit Care Med       Date:  1988-03       Impact factor: 7.598

7.  Effect of "renal-dose" dopamine on renal function following cardiac surgery.

Authors:  P S Myles; M R Buckland; N J Schenk; G B Cannon; M Langley; B B Davis; A M Weeks
Journal:  Anaesth Intensive Care       Date:  1993-02       Impact factor: 1.669

8.  The renal effects of low-dose dopamine in thermally injured patients.

Authors:  T A Graves; W G Cioffi; G M Vaughan; L Pratt; J D Heironimus; W F McManus; B A Pruitt
Journal:  J Trauma       Date:  1993-07

9.  Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine?

Authors:  G J Duke; J H Briedis; R A Weaver
Journal:  Crit Care Med       Date:  1994-12       Impact factor: 7.598

10.  Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine.

Authors:  H Stephan; H Sonntag; H Henning; K Yoshimine
Journal:  Br J Anaesth       Date:  1990-09       Impact factor: 9.166

View more
  3 in total

Review 1.  Adjunctive drug treatment in severe hypoxic respiratory failure.

Authors:  S Elsasser; H Schächinger; W Strobel
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

2.  Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients.

Authors:  Andrew J Johnston; Luzius A Steiner; Mark O'Connell; Dot A Chatfield; Arun K Gupta; David K Menon
Journal:  Intensive Care Med       Date:  2003-10-29       Impact factor: 17.440

Review 3.  Shock - Classification and Pathophysiological Principles of Therapeutics.

Authors:  Olga N Kislitsina; Jonathan D Rich; Jane E Wilcox; Duc T Pham; Andrei Churyla; Esther B Vorovich; Kambiz Ghafourian; Clyde W Yancy
Journal:  Curr Cardiol Rev       Date:  2019
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.